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Novel p27kip1 C-Terminal Scatter Domain Mediates Rac-Dependent
Cell Migration Independent of Cell Cycle Arrest Functions
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Hepatocyte growth factor (HGF) signaling via its receptor, the proto-oncogene Met, alters cell proliferation
and motility and has been associated with tumor metastasis. HGF treatment of HepG2 human hepatocellular
carcinoma cells induces cell migration concomitant with increased levels of the p27kip1 cyclin-cdk inhibitor.
HGF signaling resulted in nuclear export of endogenous p27 to the cytoplasm, via Ser-10 phosphorylation,
where it colocalized with F-actin. Introduction of transducible p27 protein (TATp27) was sufficient for actin
cytoskeletal rearrangement and migration of HepG2 cells. TATp27 mutational analysis identified a novel p27
C-terminal domain required for cell migration, distinct from the N-terminal cyclin–cyclin-dependent kinase
(cdk) binding domain. Loss or disruption of the p27 C-terminal domain abolished both actin rearrangement
and cell migration. The cell-scattering activity of p27 occurred independently of its cell cycle arrest functions
and required cytoplasmic localization of p27 via Ser-10 phosphorylation. Furthermore, Rac GTPase was
necessary for p27-dependent migration but alone was insufficient for HepG2 cell migration. These results
predicted a migration defect in p27-deficient cells. Indeed, p27-deficient primary fibroblasts failed to migrate,
and reconstitution with TATp27 rescued the motility defect. These observations define a novel role for p27 in
cell motility that is independent of its function in cell cycle inhibition.
The presence of tumor metastases is one of the most signif-
icant factors affecting survival of cancer patients (18). Meta-
static tumor growth is characterized by aberrant cell cycle
regulation, loss of cell-cell contact, increased motility, and ad-
herence to and subsequent invasion of the extracellular matrix
at a secondary site, followed by uncontrolled proliferation and
angiogenesis. However, molecular events that contribute to
metastatic progression are presently poorly understood. Sev-
eral lines of evidence suggest that hepatocyte growth factor
(HGF) (also known as scatter factor) signaling contributes to
metastasis via Met receptor signaling (10). HGF was indepen-
dently identified as a growth factor for hepatocytes and an
effector of epithelial cell motility. In normal tissues, HGF is
secreted by cells of mesenchymal origin to affect epithelial cells
expressing the Met receptor tyrosine kinase and is thought to
be involved in development and tissue regeneration (49). How-
ever, deregulated and/or constitutive HGF and/or Met signal-
ing can contribute to increased cell motility, invasion, and
proliferation in the context of tumorigenesis and metastasis
(10).
Previously it was reported that HGF signaling in human
hepatocellular carcinoma cells results in increased cell migra-
tion, actin cytoskeletal rearrangement, and elevated levels of
the p27 cyclin–cyclin-dependent kinase (cdk) inhibitor tumor
suppressor protein (28). High levels of p27 protein have also
been reported in several other human malignancies (25, 57).
p27, a member of the Cip/Kip family of cell cycle inhibitors, is
a nuclear protein that negatively regulates G1 cell cycle pro-
gression by sequestering and inactivating cyclin E or A-cdk2
complexes (19, 46). Although p27 is characterized as a tumor
suppressor, inactivating point mutations with loss of heterozy-
gosity are rarely observed in human cancer. In contrast, alter-
ation of the machinery regulating p27 protein stability has been
observed in numerous tumor cells (9, 47). Processes that reg-
ulate p27 protein degradation involve Thr-187 phosphorylation
by cyclin E-cdk2 complexes followed by SCFSkp2/Cks1 complex-
mediated ubiquitination and degradation by the 26S proteo-
some (12, 15, 48). Recently, p27 degradation has been reported
to occur in both the cytoplasm and nucleus of cells (40) and can
occur independently of Thr-187 phosphorylation (27).
Here we investigated HGF regulation of p27 protein and the
role of p27 in motility of HepG2 human hepatocellular carci-
noma cells. We found that HGF treatment resulted in phos-
phorylation of endogenous p27 on Ser-10 coupled with nuclear
export of p27 to the cytoplasm, where it colocalized with F-
actin. These results supported the hypothesis that HGF signal-
ing events position p27 for a function in cell migration. Indeed,
we identified a novel p27 C-terminal scatter domain required
for both actin cytoskeletal rearrangement and cell motility.
The activity of the p27 scatter domain was distinct from the cell
cycle inhibitory function of the N-terminal cyclin-cdk binding
domain. These results predicted a migration defect in p27-
deficient cells. Indeed, p27-deficient primary fibroblasts failed
to migrate, and reconstitution with TATp27 rescued the mo-
tility defect. Taken together, our observations define a novel
* Corresponding author. Mailing address: Howard Hughes Medical
Institute, University of California San Diego School of Medicine, La
Jolla, CA 92093-0686. Phone: (858) 534-7772. Fax: (858) 534-7797.
E-mail: sdowdy@ucsd.edu.
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role for p27 in cell motility that is independent of its function
in cell cycle inhibition.
MATERIALS AND METHODS
Generation of recombinant TATp27-transducing proteins. PCR-based strate-
gies were used to generate truncation mutants of the human p27 cDNA (33)
from the pTAT-HA-p27 expression vector (28) at amino acid residues 158 and
118. Similarly, we generated a Ser-10-Ala point mutant (p27-S10A) and a qua-
druple-point mutant, p27-QM (S140A, Q141A, A149E, and I151E). The coding
region of each plasmid was PCR amplified, with NcoI and EcoRI restriction
endonuclease recognition sites added at the N and C termini, respectively, and
was cloned into the pTAT-HA expression vector (28). Rho GTPases were cloned
into the pTAT-HA expression vector as described earlier (2, 6). All constructs
were verified by DNA sequencing. All TAT fusion proteins contain an N-termi-
nal, six-His purification tag, 11-residue (YGRKKRRQRRR) TAT protein trans-
duction domain, and hemagglutinin (HA) epitope tag. Fusion proteins were
purified as previously described (2, 28). Briefly, bacterial lysates containing
recombinant TAT fusion proteins were sonicated in 8 M urea, passed over a
Ni-nitrilotriacetic acid resin (Qiagen), eluted with imidazole, loaded in 4 M urea
onto a Mono S column attached to a fast protein liquid chromatography appa-
ratus (Amersham-Pharmacia), eluted with 1 M NaCl, and desalted into phos-
phate-buffered saline (PBS) on a Sephadex G-25 exchange column (Amersham-
Pharmacia). TAT-GTPase protein fractions from the Ni-nitrilotriacetic acid
resin were purified directly into cell culture media on the buffer exchange col-
umn. All TAT fusion proteins were sterile filtered and stored in 10% glycerol at
80°C.
Cell culture, protein transduction, and cell cycle analysis. Human HepG2
hepatocellular carcinoma cells and synchronized primary diploid human fibro-
blasts were maintained in Dulbecco’s minimal essential medium (DMEM) plus
5 and 10% fetal bovine serum, respectively, as described earlier (13, 28). p27-
deficient and strain-matched wild-type (WT) murine embryonic fibroblasts
(MEFs) were immortalized with a 3T3 protocol and were maintained in DMEM
plus 10% fetal bovine serum as described earlier (16). Cells were transduced by
addition of purified TAT fusion proteins directly to cell culture media. Trans-
duction efficiency was verified by immunoblotting for the HA epitope contained
in all TAT fusion proteins. HepG2 cells were treated with 100 nM TATp27
proteins for 6 h and trypsinized 15 min to degrade extracellular and external
membrane-bound protein. Cell pellets were washed three times with PBS and
immunoblotted with anti-HA antibodies (1:1,000; BabCo) as described earlier
(13). Where indicated, band signal intensity on immunoblots was quantified
using a Storm optical scanner (Molecular Dynamics). The functionality of
TATp27 fusion proteins was determined by cell cycle analysis of synchronized
primary diploid human fibroblasts as described earlier (13). Briefly, 48-h high-
density, contact-inhibited, G1-arrested synchronized primary diploid human fi-
broblasts were replated at low density, treated with 200 nM TATp27 fusion
proteins, and analyzed for cell cycle position by propidium iodide staining and
flow cytometry.
Immunocytochemistry and leptomycin B assays. Intracellular localization of
TATp27 fusion proteins was determined by immunostaining for the HA epitope
(present in the N-terminal leader on all TAT fusion proteins); endogenous
proteins (p27, cyclin A, cyclin B, and cdk2) were visualized by direct immuno-
fluorescence. HepG2 cells were plated into eight-well chamber slides (Nunc
Nalgene), allowed to adhere overnight, and then treated with PBS, 20 ng of HGF
(Sigma)/ml, or 100 nM TAT fusion proteins in fresh media. At given time points,
cells were washed extensively with PBS, fixed in 3.7% paraformaldehyde, per-
meabilized with ice-cold 100% ethyl alcohol, and blocked with 1% bovine serum
albumin for 10 min. Cells were incubated for 30 min at 42°C with anti-HA
(1:1,000; BabCo), anti-p27 (1:1,000; Transduction Labs), anti-cyclin A (1:500,
C-19; Santa Cruz) monoclonal antibodies, or rabbit polyclonal anti-cdk2 anti-
body (1:500, kindly provided by Helen Piwnica-Worms) (58). To control for
antibody specificity, cells were incubated with nonimmune serum or PBS. Cells
were then washed and incubated with either fluorescein isothiocyanate (FITC)-
conjugated anti-mouse immunoglobulin G (IgG) or tetramethyl rhodamine iso-
cyanate (TRITC)-conjugated anti-rabbit IgG (Sigma) for 20 min at 42°C and
mounted in the presence of Slowfade reagent (Molecular Probes). Where indi-
cated, actin filaments were visualized by staining with TRITC-conjugated phal-
loidin (100 ng/ml; Sigma) for 30 min to 1 h at room temperature. In noted cases,
cell nuclei were counterstained with 0.2 g of 4,6-diamidino-2-phenylindole
(DAPI; Sigma)/ml.
Leptomycin B assays were performed by plating HepG2 cells into eight-well
chamber slides and treated with either PBS or 20 ng of HGF/ml for 20 h. Culture
media were exchanged, and 10 ng of leptomycin B/ml was added with or without
HGF for 3 h at 37°C followed by immunocytochemistry as described above using
monoclonal antibodies to p27 (1:500) or cyclin B (1:200; Santa Cruz). Randomly
selected fields were analyzed, and individual cells were scored for nuclear, cyto-
plasmic, or nuclear-cytoplasmic staining.
Analysis of p27 phosphorylation status. HepG2 cells were treated with either
PBS or 10 ng of HGF/ml for 16 h, starved of phosphate for 45 min, and then
labeled with 3.75 mCi of 32PO4 for 4 h in the presence of either HGF or PBS.
Cells were lysed in immunoprecipitation buffer (250 mM NaCl, 50 mM HEPES,
2 mM EDTA, 0.5% NP-40, including dithiothretiol, aprotinin, phenylmethylsul-
fonyl fluoride, and leupeptin), precleared with zysorbin (Zymed), and immuno-
precipitated overnight with anti-p27 monoclonal antibody plus protein G Sepharose.
Immunoprecipitates were resolved by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and transferred to nitrocellulose. The same membrane was used
to detect both 32P-labeled p27 by phosphorimager analysis and total p27 protein
levels by immunoblotting using polyclonal anti-p27 (1:1,000). Phospho-specific
antibodies to Thr-187 and Ser-10 of p27 were used to detect phosphorylation
status of respective residues (5). Lysates from HepG2 cells that were treated with
HGF or PBS control for 24 h were immunoprecipitated using monoclonal anti-
body to p27, followed by immunoblotting using anti-p27 (1:1,000), anti-phospho-
Thr-187 (1:200), and anti-phospho-Ser-10 (1:500) polyclonal antibodies.
HepG2 cell migration assay. HepG2 cells were plated at low density to form
discrete 5- to 10-cell colonies and were allowed to adhere overnight. PBS, 5 ng
of HGF/ml, or 100 nM TAT fusion proteins were added to fresh cell culture
media for indicated periods. Colonies were considered positive for scattering if
cell-cell contact was lost and if the distance between cells increased upon mi-
croscopic observation. Cells were fixed and stained with hematoxylin, and digital
images were used to quantify cell distances. The distance between colony cell
nuclei was measured at 0 h and subtracted from that at 8 or 24 h to yield the
average total distance of cell migration.
PI3-K inhibition. HepG2 cells were plated at low density and allowed to
adhere overnight. To assess the role of phosphatidylinositol 3-kinase (PI3-K) in
early events in p27-dependent migration, cells were pretreated for 20 min with 30
nM wortmannin and were then treated with either 5 ng of HGF/ml or 100 nM
TATp27 protein. For analysis of later events cells were treated with either 5 ng
of HGF/ml or 100 nM TATp27 protein, after which 30 nM wortmannin was
added at 8 h. In both cases, HepG2 cell migration assays were performed 24 h
after addition of HGF or TATp27.
MEF and 3T3 migration assay. Cell migration of p27/ MEFs was compared
to that of MEFs from matched WT embryos by using a migration assay on a
confluent monolayer (54). Briefly, subconfluent MEFs in six-well plates were
incubated overnight with DMEM plus 0.1 to 0.5% FCS. The confluent mono-
layers were scraped with either a rubber policeman or the edge of a sterile
microtome blade (model 818; Leica Instruments GmbH) in an area measuring
approximately 1.5  0.3 cm. To measure cell migration, the cultures were incu-
bated at 37°C for 24 h, washed with PBS, fixed with absolute methanol, and
stained with hematoxylin. Cells that had migrated into the denuded area were
observed by using an Axiovert 25 microscope (Carl Zeiss, Inc.) (100 magnifi-
cation). Random fields were observed along the wound edge in duplicate culture
wells. Reconstitution of p27 was performed by addition of 100 nM TATp27
proteins at the time of denuding. Cells were fixed, stained with hematoxylin, and
photographed 24 h posttreatment.
RESULTS
HGF signals nuclear export of endogenous p27 that is me-
diated by Ser-10 phosphorylation. HGF treatment of HepG2
human hepatocellular carcinoma cells results in elevated p27
protein levels (28). The majority of p27 regulation occurs via
posttranslational mechanisms, including phosphorylation and
subcellular localization, events that are often deregulated in
cancer cells (47). Therefore, we investigated the effects of Met
receptor activation by HGF on the subcellular distribution of
p27 protein over time by immunocytochemistry. p27 remained
nuclear in control PBS-treated cells throughout the time
course as determined by counterstaining with DAPI (Fig. 1A,
left panels). In contrast, HGF treatment of HepG2 cells re-
sulted in redistribution of p27 from the nucleus to the cyto-
plasm in a time-dependent fashion (Fig. 1A, right panels). p27
was first detected in the cytoplasm of HGF-treated cells at
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FIG. 1. HGF signaling induces nuclear export of p27. (A) Analysis of p27 localization. Human HepG2 hepatocellular carcinoma cells treated
with PBS control (left panels) or HGF (20 ng/ml; right panels) were analyzed for endogenous p27 localization by immunocytochemistry. At
indicated time points, cells were stained with anti-p27 antibodies and FITC-conjugated anti-mouse IgG (green). Corresponding cell nuclei were
visualized by DAPI (blue). Results represent a minimum of four independent observations. (B) p27 phosphorylation status. HepG2 cells treated
with HGF for 20 h were metabolically labeled with [32P]orthophosphate followed by anti-p27 immunoprecipitation (IP) (top panel). Total p27
protein levels were determined by anti-p27 immunoblotting (bottom panel). (C) HGF-dependent Ser-10 phosphorylation. p27 was immunopre-
cipitated from lysates of control and HGF-treated HepG2 cells with pan-anti-p27 antibodies followed by immunoblot analysis with anti-phospho-
Thr-187 (top panel), anti-phospho-Ser-10 (middle panel), and pan-anti-p27 (bottom panel) antibodies. (D) Time course of HGF-dependent Ser-10
phosphorylation. HepG2 cells were treated in the presence of HGF () or PBS control (). At indicated time points, cells were lysed and total
p27 was immunoprecipitated. Relative levels of phospho-Ser-10 were determined by Western blotting using the anti-phospho-Ser-10 antibodies.
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12 h, and by 24 h, the majority of p27 was present in the
cytoplasm (Fig. 1A, right panels). Inhibition of Crm1-depen-
dent nuclear export by leptomycin B prevented cytoplasmic
accumulation of endogenous p27 in HGF-treated cells (data
not shown), suggesting that HGF signaling specifically regu-
lates p27 nuclear export.
p27 protein stability and localization are regulated by phos-
phorylation events (8, 47). Therefore, we examined the phos-
phorylation status of p27 in HGF-treated cells by [32P]ortho-
phosphate metabolic labeling followed by p27
immunoprecipitation. HGF-treated cells, containing predomi-
nantly cytoplasmic p27, showed a significant level of endoge-
nous p27 phosphorylation compared to the level of p27 from
control cells (Fig. 1B).
We next determined the phosphorylation status of specific
p27 residues in response to HGF signaling. Phosphorylation of
p27 on Thr-187 initiates ubiquitin-mediated degradation of
p27 (12, 53). Ser-10 was identified as a predominant site of p27
phosphorylation that both increases protein stability and me-
diates nuclear export of p27 to the cytoplasm in a Crm1-
dependent manner (21, 40). We performed p27 immunoblot
analyses using phospho-specific antibodies to Ser-10 and Thr-
187 (5, 40). Total p27 was immunoprecipitated from lysates of
HepG2 cells grown in 5% serum plus or minus HGF for 24 h,
followed by immunoblotting. Low levels of Thr-187 phosphor-
ylation were equally detected in HGF and control-treated cells
(Fig. 1C, top panel). In contrast, Ser-10 phosphorylation was
increased in HGF-treated cells compared to that in control
cells (Fig. 1C, middle panel). To establish temporal coordina-
tion of p27 phosphorylation and nuclear export, Ser-10 was
measured over a 24-h time course in the presence of HGF or
PBS control. Ser-10 phosphorylation remained consistently
low in control PBS-treated cells over 24 h (Fig. 1D). In con-
trast, HGF treatment increased p27 Ser-10 phosphorylation at
12 h, with maximal levels achieved by 24 h (Fig. 1D). These
data correlate with the appearance of p27 in the cytoplasm of
HGF- treated cells.
Cytoplasmic p27 is not associated with cyclin-cdk complexes
but colocalizes with actin in HGF-treated cells. p27 binds cy-
clin A-cdk2 complexes to inhibit their activity (3, 37). There-
fore, to determine whether nuclear export of p27 involved
concomitant export of cyclin-cdk2 complexes, HGF- and con-
trol-treated HepG2 cells were analyzed by immunocytochem-
istry for endogenous cyclin A and cdk2 localization. Although
p27 was exported to the cytoplasm in HGF-treated cells, both
cyclin A and cdk2 remained localized to the nucleus after 24 h
of HGF or control treatment with little or no detectable dif-
ference between either group (Fig. 2A). These observations
demonstrate that HGF-dependent nuclear export of p27 to the
cytoplasm does not involve accompanying export of cyclin A-
cdk2 complexes.
Cellular responses to HGF treatment include increased mo-
tility associated with extensive rearrangement of the actin cy-
toskeleton, including filopodium and lamellipodium formation
(49). Therefore, we investigated endogenous p27 localization
with respect to F-actin. HepG2 cells were treated for 24 h with
HGF and triply stained for endogenous p27 (green), F-actin
(red), and nuclei or DNA (blue) (Fig. 2B). HGF-treated cells
contained a substantial amount of endogenous p27 colocalized
with F-actin at both the membrane and in areas of organized
actin filaments (Fig. 2B, bottom right panel). Taken together,
these observations demonstrate that HGF signaling results in
the specific export of endogenous nuclear p27 to the cyto-
plasm, where it colocalizes with F-actin, exclusive of cyclin
A-cdk2 complexes.
Identification of a novel p27 C-terminal domain necessary
for cell migration. The kinetics of p27 nuclear export and
colocalization with F-actin in the cytoplasm of HGF-treated
cells suggested that p27 may be playing a role in cell migration.
Previously, it was established that transduction of full-length
TATp27-WT protein into HepG2 cells was sufficient for both
cell migration and filopodium formation (28). In contrast,
transduction of TATp27–N-terminal protein (residues 1 to
103), which retained the cyclin-cdk binding domain, was insuf-
ficient to induce either phenotype, suggesting that p27 C-ter-
minal elements are required to mediate cell migration.
Although the C-terminal portion of p27 outside the cyclin-
cdk binding domain is evolutionarily conserved, little is known
about its structure or function. To determine the C-terminal
p27 structural elements required for cell migration, we gener-
ated a series of transducible TATp27 C-terminal truncation
proteins and point mutations in full-length TATp27 protein
(Fig. 3A). All TATp27 fusion proteins were expressed in bac-
teria, purified under similar conditions, and contained an N-
terminal leader containing the 11-amino-acid TAT protein
transduction domain, six-His purification tag, and HA epitope
tag.
To assess the transduction efficiency of TATp27 fusion pro-
teins, HepG2 cells were treated with an equal concentration of
each protein for 1 h, washed extensively, fixed, and analyzed by
anti-HA immunocytochemistry. Consistent with other trans-
ducible TAT fusion proteins (55), all TATp27 fusion proteins
transduced into cells and were visualized equally in the cyto-
plasm and nucleus of cells 1 h after addition to the media (Fig.
3B). In addition, immunoblotting for the HA epitope in lysates
from HepG2 cells treated with TATp27 fusion proteins and
trypsinized to remove any extracellular TATp27 protein inde-
pendently confirmed transduction of TATp27 proteins into
cells (data not shown).
The altered molecular weight of TAT fusion proteins al-
lowed for assessment of intracellular TATp27 protein levels
relative to endogenous p27 protein over time. Cells transduced
with TATp27-WT protein were trypsinized at indicated time
points, resuspended in cell lysis buffer, and immunoblotted for
total p27 protein. Quantification of band intensity indicated
that the maximal level of intracellular TATp27-WT protein
was 2.5-fold above that of endogenous p27 within the same cell
populations (Fig. 3C). Furthermore, TATp27-WT protein was
detectable 24 h after treatment (Fig. 3C). All Tatp27-fusion
proteins that retained an intact N-terminal cyclin-cdk bind-
ing domain (TATp27-WT, TATp27-158, TATp27-118, and
TATp27-QM) induced a G1 cell cycle arrest, whereas TATp27
fusions containing a mutation in the cdk binding domain
(TATp27-KK) and the C terminus alone (TATp27-C) failed
to induce a cell cycle arrest (data not shown). Taken together,
these observations confirm that TATp27-fusion proteins trans-
duce into cells and maintain intracellular biological activity to
induce G1 cell cycle arrest.
To directly test the involvement of p27 in cell migration,
small colonies of 5 to 10 HepG2 cells were treated with PBS
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control, HGF, or TATp27-WT protein and observed over a
24-h period. Cell migration was defined by loss of cell-cell
contact and increased distance between cells in a colony. Con-
trol PBS-treated cells retained cell-cell contacts and main-
tained discrete colonies with average distances between cell
nuclei of less than 3 m (Fig. 4A and B). HGF treatment
resulted in disruption of cell-cell contacts and accumulation of
significant distances between colony cell nuclei in excess of 15
m (Fig. 4A and B). Treatment of cells with TATp27-WT
protein induced cell migration to distances nearly identical to
those caused by HGF treatment (Fig. 4A and B). TATp27-WT
protein induced a greater extent of cell scattering than did
HGF treatment at 8 h, whereas the two treatments resulted in
similar migration distances by 24 h (Fig. 4B, right panel),
indicating that direct transduction of TATp27-WT protein ac-
celerates the rate of cell migration.
Transduction of the N-terminal half of p27 containing the
functional cyclin-cdk binding domain fails to induce cell mi-
gration (28). Therefore, to delineate the region of p27 required
for cell migration, we examined the ability of TATp27-158 and
TATp27-118 C-terminal truncation proteins to induce scatter-
ing. TATp27-158 protein induced cell migration to distances
similar to those of HGF and TATp27-WT protein treatments
(Fig. 4A and B). In contrast, TATp27-118 C-terminal trunca-
tion protein failed to disrupt cell-cell contacts and maintained
cell-cell distances of less than 3 m (Fig. 4A and B). These
data indicate that p27 contains a scatter domain between res-
idues 118 to 158 that is required for p27-induced cell motility.
Functional similarities between p27 and Far1p. Analogous
to HGF treatment of mammalian cells, -factor treatment of
yeast cells results in nuclear export of Far1p, a cyclin-cdk
inhibitor, to the cytoplasm followed by reorientation of the
actin cytoskeleton into a shmoo structure (4, 36). Therefore,
we compared the sequence of the p27 scatter domain (residues
FIG. 2. p27 localizes with actin, and cyclin A-cdk2 complexes remain nuclear. (A) Cyclin A and cdk2 localization in HGF-treated cells. HepG2
cells treated with control PBS or HGF for 24 h were analyzed by immunocytochemistry for cyclin A (FITC; green) and cdk2 (TRITC; red)
localization. Corresponding nuclei were counterstained with DAPI (blue). (B) p27 colocalizes with F-actin. HepG2 cells treated with HGF for 24 h
were analyzed by immunocytochemistry for endogenous p27 (FITC; green) and F-actin (TRITC; red) localization. Corresponding nuclei were
counterstained with DAPI (blue). Arrows indicate areas in merged image with colocalized (yellow) cytoplasmic p27 and F-actin.
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118 to 158) to the C terminus of Far1p involved in shmoo
formation. Although there is limited sequence identity be-
tween the two distantly related and functionally analogous
proteins, an SQx7AxI motif present within the p27 scatter
domain (residues 140 to 151) was found in the Far1p C-termi-
nal Cdc42p/Bem1p/Cdc24p-binding region (Fig. 3A).
To test the requirement of this motif for p27-mediated cell
migration, we generated a transducible full-length p27 protein
that contained a mutation of each residue, termed TATp27-
QM (Fig. 3A). TATp27-QM protein efficiently transduced into
cells and induced a G1 cell cycle arrest (Fig. 3B and data not
shown). However, TATp27-QM protein treatment failed to
FIG. 3. Generation of transducible TATp27 fusion proteins. (A) Schematic representation of TATp27 fusion proteins. N-terminal leader
contains the 11-amino-acid TAT protein transduction domain, HA epitope tag, and six-histidine purification tag. CBD, cyclin-cdk binding domain
of p27. TATp27-WT represents full-length WT p27 protein, whereas TATp27-158 and TATp27-118 designate terminal truncations at respective
residues. TATp27-QM contains four single-point mutations in the actin-interacting domain of the Far1p-like motif. TATp27-KK contains two
inactivating point mutations that disrupt p27 binding to cyclin-cdk complexes. TATp27-S10A contains an alanine substitution for serine at residue
10. (B) Intracellular localization of TATp27 proteins. HepG2 cells were treated with control PBS or transducible TATp27 proteins and visualized
by immunocytochemistry 1 h after transduction with anti-HA antibody and FITC-conjugated secondary antibody. (C) Immunoblot comparison of
TATp27 and endogenous p27 protein levels in transduced cells. Lysates from HepG2 cells transduced with 100 nM TATp27-WT were immuno-
blotted for total p27 at indicated time points, and band intensity was quantified. The largest increase of TATp27 over endogenous p27 at any time
point was 2.5-fold.
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FIG. 4. p27-dependent cell migration requires a C-terminal scatter domain and Ser-10 phosphorylation-dependent nuclear export. (A) Effect
of TATp27 proteins on cell migration. HepG2 cells were treated for 24 h with control PBS, HGF, or TATp27 fusion protein as indicated and
observed for cell scattering. The scattering phenotype is characterized by loss of cell-cell contact and increased distance between neighboring cells.
(B) Quantification of cell migration. Cells treated for panel A above were stained with hematoxylin and recorded by digital microscopy at 0, 8, and
24 h posttreatment. Distance between colony nuclei measured at 0 h was subtracted from distance at 8 or 24 h to calculate average distance of
migration. Data represent a minimum of 50 random fields and 300 measurements per treatment for each of three separate experiments.
(C) TATp27 protein localization in response to HGF. HepG2 cells were treated with control PBS (left panels) or HGF (right panels) for 20 h,
followed by treatment with control PBS, TATp27-WT protein, or TATp27-S10A protein for an additional 3 h. TATp27 proteins were visualized
by immunostaining with anti-HA antibodies (HA epitope tag is present in the N-terminal leader of all TAT fusion proteins) and FITC–anti-mouse
IgG (green). Corresponding nuclei were counterstained with DAPI (blue).
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induce migration of HepG2 cells (Fig. 4A and B). In addition,
while TATp27-WT localized to areas of dynamic actin rear-
rangement, both TATp27-QM and TATp27-118 proteins,
which fail to induce cell migration but are exported to the
cytoplasm, localized to perinuclear regions and were absent
from actin-based structures at the cell membrane (data not
shown). These observations indicate that the SQx7AxI motif
present in the p27 scatter domain is critical for the ability of
p27 to induce cell migration and to interact with actin-remod-
eling complexes at the cell membrane.
p27-induced scattering is independent of cell cycle arrest
and requires cytoplasmic localization. Although the scatter
domain is necessary for p27-dependent migration, transduc-
tion of the p27 C-terminal scatter domain alone (residues 108
to 198) was insufficient for cell scattering (data not shown). p27
was originally identified as an inhibitor of G1 cell cycle pro-
gression (19, 46); therefore, we tested whether p27 must retain
its cell cycle arrest function in order to induce cell migration.
HepG2 cells were transduced with TATp27-KK protein con-
taining a mutation in the cyclin binding domain (26), which
fails to mediate G1 cell cycle arrest. TATp27-KK protein in-
duced cell scattering to a distance comparable to that caused
by HGF and TATp27-WT protein treatments (Fig. 4A and B).
Thus, the ability of p27 to mediate cell cycle arrest is not a
requirement for its function in cell migration.
We next examined the requirement of p27 Ser-10 phosphor-
ylation for cell migration (22, 40). A transducible full-length
p27 protein was generated containing a Ser-to-Ala mutation at
position 10 (TATp27-S10A) (Fig. 3A). TATp27-S10A protein
transduced into cells and induced a G1 cell cycle arrest (data
not shown). However, TATp27-S10A protein failed to induce
migration of HepG2 cells (Fig. 4A and B), suggesting that
Ser-10 phosphorylation is required for p27-mediated cell mi-
gration.
To confirm that cytoplasmic localization of p27 is necessary
for function of the scatter domain, we examined the intracel-
lular localization of TATp27 proteins in response to HGF
treatment. Both TATp27-WT and TATp27-S10A proteins
were present in the nucleus of control PBS-treated cells 3 h
after transduction (Fig. 4C, left panels). Consistent with HGF-
dependent cytoplasmic localization of endogenous p27 (Fig.
1A), TATp27-WT protein was exported from the nucleus to
the cytoplasm in HGF-treated cells (Fig. 4C, right panels).
TATp27-158, TATp27-118, and TATp27-QM proteins were
also exported from the nucleus in an HGF-dependent fashion
(data not shown). In contrast, TATp27-S10A protein remained
in the nuclei of HGF-treated cells (Fig. 4C, right panels).
Taken together, these observations establish that p27-medi-
ated cell migration requires Ser-10 phosphorylation-dependent
cytoplasmic localization of p27 bearing an intact C-terminal
scatter domain (residues 118 to 158) but not a functional cy-
clin-cdk binding domain.
The p27 scatter domain induces actin cytoskeletal rear-
rangement in a Rac-dependent manner. Rearrangement of the
actin cytoskeleton during cell migration is mediated by the Rho
family of GTPases, specifically Rho, Rac, and Cdc42 (17, 32).
In particular, the activities of Rac and Cdc42 are coordinated
at the leading edge of cells to form lamellipodia and filopodia,
respectively (38). HGF induces cytoskeletal rearrangement
that is required for motility of a number of cell lines (20, 39,
52) and specifically induces formation of filopodia (28) and
membrane ruffling (data not shown) in HepG2 cells. There-
fore, we examined the dependency of cytoskeletal rearrange-
ment on the p27 scatter domain. Formation of both filopodia
and lamellipodia was observed in cells transduced with
TATp27-WT and TATp27-158 proteins bearing an intact scat-
ter domain but not in cells transduced with TATp27-118 or
TATp27-QM protein (Fig. 5A). Transduction of constitutively
active forms of Cdc42 (TATCdc42-V12), Rac (TATRac-V12),
and Rho (TATRho-V14) induces formation of filopodia, la-
mellipodia, and stress fibers, respectively, in less than 15 min
(2, 6) (Fig. 5A; data not shown). However, similar to HGF-
induced cytoskeletal rearrangement, TATp27-WT- and
TATp27-158-induced formation of lamellipodia and filopodia
occurred in a time course consistent with induction of cell
migration. These observations suggest that, while the scatter
domain is required for p27-dependent cytoskeletal rearrange-
ment, p27 does not activate Rho family GTPases directly upon
transduction into cells.
We next used transducible forms of Rho GTPases to deter-
mine the specific family member(s) involved in p27-mediated
HepG2 cell migration. Although dominant-negative TATCdc42-
N17 blocked p27-induced formation of filopodia (data not
shown), it failed to inhibit p27-dependent migration (Fig. 5B
and data not shown). In contrast, dominant-negative TATRac-
N17 inhibited p27-mediated migration in a dose-dependent
fashion (Fig. 5B and C), suggesting that activated Rac is nec-
essary for p27-dependent migration. However, although trans-
duction of constitutively active TATRac-V12 alone induced
lamellipodia, it was not sufficient for induction of cell migra-
tion (Fig. 5C), suggesting that p27 provides signals necessary
for Rac-mediated migration.
PI3-K inactivation partially inhibits p27-dependent migra-
tion. PI3-K is required for HGF-mediated motility of some
epithelial cell types in cell culture and can activate Rac (10). To
test the involvement of PI3-K activation in p27-dependent
migration, we used wortmannin to inhibit PI3-K activity. Wort-
mannin was added to cells either before or 8 h after treatment
with HGF or TATp27-WT protein. Consistent with previously
published reports, wortmannin inhibited HGF-induced cell mi-
gration at both time points (Fig. 5D). However, p27-dependent
migration was only partially inhibited in cells either pretreated
with wortmannin or treated with wortmannin at 8 h (Fig. 5D),
suggesting that some aspects of p27-mediated migration were
downstream and/or independent of PI3-K signaling.
p27-deficient cells fail to migrate. To genetically confirm the
placement of p27 in a cell motility pathway, we examined the
ability of WT and p27-deficient primary MEFs to migrate in a
standard cell culture migration assay. MEFs isolated from WT
mice efficiently migrated into the denuded region in 24 h (Fig.
6A, left panel). In contrast, p27-deficient MEFs from strain-
matched mice failed to migrate (Fig. 6A, right panel). These
observations demonstrated that nonepithelial cells were also
dependent on p27 function for migration under these condi-
tions.
To determine if basal migratory activity of fibroblasts was
related to p27 status, WT NIH 3T3 fibroblasts were examined
for p27 localization and phosphorylation. NIH 3T3 cells effi-
ciently migrated into a denuded region in the standard cell
migration assay (data not shown), suggesting that the immor-
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FIG. 5. Rac GTPase is required for p27-dependent cell migration. (A) TATp27 induces formation of both filopodia and lamellipodia. HepG2
cells were treated with 100 nM TATp27, TATCdc42-V12, or TATRac-V12 fusion proteins as indicated, and F-actin polymerization was visualized
by TRITC-conjugated phalloidin. Formation of actin microspikes (filopodia) and membrane ruffling (lamellipodia) were observed only in cells
transduced with control TATCdc42-V12 or TATRac-V12 fusion proteins and TATp27-fusion proteins containing an intact scatter domain. (B) Rac
dominant-negative blocks p27-mediated scattering. HepG2 cells were treated simultaneously with 100 nM TATCdc42-N17 or TATRac-N17
dominant-negative proteins (as indicated) plus 100 nM TATp27-WT protein. Cell migration was scored at 24 h. (C) Quantification of inhibitory
effect of Rac dominant negative. HepG2 cells were treated as for panel B with TATp27-WT protein and various concentrations of TATRac-N17
dominant-negative protein or 100 nM constitutively active TATRac-V12 protein alone. Cell migration was scored at 24 h. (D) Effect of wortmannin
(Wort) on cell migration. HepG2 cells were treated with 5 ng of HGF/ml or 100 nM TATp27-WT. Thirty nanomolar wortmannin was added at
either 0 or 8 h, and cell migration was quantified 24 h after transduction.
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talization process does not interfere with this pathway. Immu-
nocytochemical analysis of NIH 3T3 cells demonstrated that
p27 is localized to the cytoplasm of cells in both dense and
denuded regions of the plate (Fig. 6B). Consistent with this
result, p27 cytoplasmic localization has been observed in Swiss
3T3 fibroblasts (56). The phosphorylation status of Ser-10 was
determined in NIH 3T3 cells grown at high and low densities
in the presence of high and low serum concentrations. p27 was
constitutively phosphorylated on Ser-10 under all conditions
(Fig. 6C).
We next examined the ability of TATp27-WT protein to
restore migration of p27-deficient 3T3 fibroblasts. Consistent
with nonimmortalized MEFs, p27-deficient immortalized 3T3
derivates also failed to migrate (Fig. 6D, left panel), demon-
strating that p27 was essential for cell migration after immor-
talization. Both TATp27-WT and TATp27-158 proteins com-
FIG. 6. Reconstitution of p27 rescues a migration defect of p27/ fibroblasts. (A) Migration analysis of WT and p27-deficient MEFs. A wound
area was mechanically induced by a single passage of a microtome blade across culture plate surface to confluent MEF monolayers. After 24 h,
cells were fixed and stained with hematoxylin. The experiment was repeated three times with indistinguishable results. The wound edge is noted
as a digitally drawn line over the image. (B) p27 is localized to the cytoplasm of NIH 3T3 cells. WT NIH 3T3 cells were subject to the standard
cell migration assay and immunostained for p27 localization (left panels). Corresponding nuclei were stained with DAPI (right panels). (C) p27
is constitutively phosphorylated on Ser-10 in NIH 3T3 cells. Total p27 was immunoprecipitated (IP) from lysates of WT cells grown under indicated
conditions. Immunoprecipitates were blotted for phospho-Ser-10 and total p27 antibodies. (D) p27 protein rescues cell migration defect. Confluent
p27-deficient 3T3 cells were subjected to the wound migration assay described for panel A, by single passage of a rubber policeman followed by
treatment with transducible TATp27 proteins. p27-WT and p27-158 proteins rescued the wound migration defect, whereas mock treatment (PBS)
and TATp27-118 protein (lacking the p27 scatter domain) failed to induce cell migration. The wound edge is noted as a digitally drawn line over
the image.
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plemented the migration defect in p27-deficient 3T3 cells (Fig.
6D). In contrast, TATp27-118 protein containing a deleted C
terminus failed to rescue the migration defect in p27-deficient
3T3 cells (Fig. 6D). Taken together, these observations dem-
onstrate a role for p27 in a cell motility pathway that functions
in both epithelial and fibroblast cells that is independent of G1
cell cycle arrest functions of p27.
DISCUSSION
Metastatic tumor growth is one of the most important fac-
tors in predicting the survival of cancer patients. HGF/c-Met
signaling mediates phenotypes characteristic of tumor progres-
sion and enhanced metastatic potential (23, 41). HGF treat-
ment of hepatocellular carcinoma cells results in increased cell
motility, actin cytoskeletal rearrangement, and, paradoxically,
stabilization of the p27 tumor suppressor protein. Although
several studies have correlated a poor patient outcome with
loss or low levels of p27 protein in multiple human malignan-
cies (9, 47), high levels of p27 tumor suppressor protein have
been reported in a subset of human malignancies, including
esophageal, colon, breast, and small-cell lung carcinoma (11,
14, 45, 57). Recently, a subset of invasive breast carcinomas
were characterized with high p27 protein levels that correlated
with lymph node metastasis (25). Consistent with this obser-
vation, cytoplasmic localization of p27 has been associated with
anchorage-independent growth in culture and aggressive tu-
mor progression (7, 30, 31, 43). These observations suggest the
potential for alternative functions of p27 in addition to its role
in cell cycle inhibition. Indeed, here we define a novel role for
p27 in cell motility in response to HGF signaling that is inde-
pendent of the G1 cell cycle arrest functions of p27.
The data presented here support a model in which an HGF-
activated kinase phosphorylates p27 on Ser-10, resulting in
nuclear export of p27 to the cytoplasm (Fig. 7). These events
position p27 for its function in cell migration and cytoskeletal
rearrangement. Consistent with these observations, we de-
tected cytoplasmic p27 in areas of dynamic cytoskeletal rear-
rangement. Importantly, the ability of p27 to induce cell mi-
gration mapped to a C-terminal scatter domain (residues 118
to 158) that was independent of previously described cell cycle
arrest functions of p27 that reside in the N terminus. Loss or
disruption of the C-terminal p27 scatter domain abolishes both
actin rearrangement and cell scattering. However, the scatter
domain alone is insufficient for cell migration because p27
must be exported to the cytoplasm via Ser-10 phosphorylation.
This conclusion is further supported by the observation that
TATp27-C (residues 108 to 198), which does not induce cell
scattering, is retained in the nucleus of transduced cells (un-
published observation).
The involvement of p27 in actin cytoskeletal rearrangement
is evolutionarily reminiscent of -factor pheromone signaling
in yeast. Far1p, the yeast cell cycle inhibitor, mediates both G1
cell cycle arrest and shmoo formation, which orients the actin
cytoskeleton toward an opposite mating partner (35). In re-
sponse to -factor, Far1p translocates from the nucleus to the
cytoplasm and interacts with cdc42p (4). Consistent with this
functional analogy, mutation of a Far1p-like sequence motif
present in the p27 scatter domain inactivates both cell migra-
tion and actin rearrangement but preserves the cell cycle arrest
functions of p27.
In a manner similar to HGF treatment, transduced p27
protein induces formation of both lamellipodia and filopodia,
suggesting that activation of Rac and/or Cdc42 is a down-
stream event in a p27-dependent pathway. Transduction or
microinjection of constitutively active Rac or Cdc42 protein
into cells results in the expected phenotype in less than 10 min
(2, 29). However, the first signs of membrane ruffling and cell
migration in TATp27- or HGF-treated cells are not detectable
until 4 h posttreatment, even though TATp27 reaches an
intracellular maximum concentration in15 min. Therefore, it
is unlikely that unmodified p27 is capable of immediately ac-
tivating Rac or Cdc42 directly. Rate-limiting events such as p27
posttranslational modification or assembly into macromolecu-
lar complexes may be required during the initiation of p27-
dependent cell migration in order for p27 to activate Rho
GTPases.
Migratory responses to Met activation proceed in two stages:
an early stage that occurs during the first 6 h after treatment
and involves cytoskeletal extension, spreading, and detachment
of cell-cell contacts and a later stage involving cell scattering
that is not observed until 16 to 20 h after treatment (34, 39, 50).
Importantly, the relatively long period (8 to 24 h) before the
onset of TATp27-mediated scattering is consistent with the
time course of HGF-mediated migration described in MDCK
cells (34, 39) and human colon cancer cell lines (24). This type
of prolonged signaling is also observed in normal human hepa-
tocytes and HepG2 cells, where HGF-Met activation is sus-
tained up to 28 h (44). The time at which endogenous p27 is
observed in the cytoplasm of HGF-treated cells (12 to 24 h)
and at which TATp27-WT is observed predominantly in the
FIG. 7. Model of HGF signaling through p27 to mediate cell mi-
gration. HGF binding to the Met receptor activates HGF-activated
kinase (HACK), which phosphorylates p27 on Ser-10. Phosphorylation
of Ser-10 is required for export of p27 from the nucleus to the cyto-
plasm in a Crm1-dependent fashion. In the cytoplasm, p27 interacts
directly or indirectly with actin-remodeling proteins, thereby inducing
cytoskeletal rearrangement accompanied by Rac-dependent cell mi-
gration. p27-dependent cell migration requires Ser-10 phosphorylation
and the p27 scatter domain (residues 118 to 158) but not a functional
cyclin-cdk binding domain.
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cytoplasm of transduced cells correlates precisely with the ap-
pearance of cell migration.
PI3-K is involved in early scatter responses to HGF, includ-
ing dissociation of adherens junctions (34, 42) and activation of
Rac (10). In the present study, PI3-K inactivation completely
inhibited HGF-mediated scattering but only partially inhibited
p27-dependent migration. Furthermore, we demonstrated that
p27 accelerates the rate of cell migration compared to HGF at
the 8-h time point. Taken together, these data suggest that p27
has a role in both early and late migration events that both
involves PI3-K signaling and also appears independent of
PI3-K.
Our model therefore predicts a motility defect in p27-defi-
cient cells. Indeed, p27-deficient fibroblasts failed to migrate in
culture. Rescue of the cell migration defect in p27-deficient
MEFs and 3T3 cells by p27 reconstitution genetically places
p27 in a cell motility pathway independently of its cell cycle
arrest functions. Furthermore, these data broaden the impor-
tance of p27-dependent motility, as hepatocytes are epithelial
cells that express the Met receptor, whereas fibroblasts do not
express Met (51), suggesting that p27 can mediate cell migra-
tion independently of Met receptor signaling. Indeed, devel-
opment and tissue regeneration following injury are biological
processes that require specific regulation of cell migration and
the cell cycle. Consistent with this notion, rodent models of
partial hepatectomy show significantly increased levels of p27
that are detected in both nuclear and cytoplasmic fractions (1).
Taken together, these observations suggest a novel role for p27
in cell migration that is independent of cell cycle arrest func-
tion with potential implications in wound healing and metas-
tasis.
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